Watch the webcasts from our industry partners' Satellite Symposia.
08/12/2022
Bristol Myers Squibb
Exploring new advancements in chemokine signaling in tumor biology: Focus on IL-8, CXCR1, and CXCR2
- Welcome and introductions
Vincenzo Bronte - Spotlight on I-O: Chemokine signaling and its role in tumor development and I-O resistance
Vincenzo Bronte - Caught in a NET: Reviewing IL-8, CXCR1, and CXCR2 signaling in tumor biology
Ignacio Melero - Emerging data for targeting IL-8, CXCR1, and/or CXCR2 as potential treatment options in solid tumors
Matteo Simonelli - Closing remarks and audience Q&A
Vincenzo Bronte
09/12/2022
GSK
The need to advance checkpoint blockade for cancer immunotherapy and the potential role of the CD226 Axis
- Why is there a need to build on current immune checkpoint therapies?
Solange Peters - What is the CD226 Axis?
Solange Peters - How does the CD226 Axis regulate antitumor responses?
Luis Paz-Ares - How is the CD226 Axis being studied in clinical trials?
David Planchard - Panel discussion / Q&A
Solange Peters